Meta to Layoff 20%, AI Cured Dogs Cancer, Nvidia's New Chip

Summary

In this episode, we discuss significant AI-related news, including a personalized cancer vaccine developed with AI tools for a dog, NVIDIA's upcoming AI chip reveal, and OpenAI's major enterprise venture. We also cover Meta's potential large-scale layoffs to fund its ambitious AI spending, highlighting a broader trend of workforce restructuring across the…

Key takeaways

• A non-biologist used ChatGPT and AlphaFold to design a personalized mRNA cancer vaccine for his dog, shrinking the tumor 75%—previewing AI-driven precision medicine that Moderna, Merck, and BioNTech are already testing in humans.
• Meta is preparing to cut over 20% of its workforce (15,000+ employees) while committing $115–135B in AI capex this year, part of a broader ~$700B AI infrastructure wave across Amazon, Microsoft, Alphabet, and Meta.
• OpenAI is negotiating a ~$10B joint venture with major PE firms (TPG, Bain Capital, Advent, Brookfield) to deploy AI tools across thousands of portfolio companies, signaling a shift from one-off enterprise sales to portfolio-scale AI adoption.

Why this matters

The convergence of massive AI capital expenditures, workforce restructuring at scale, and AI deployment through private equity channels signals that 2026 marks the inflection point where AI transitions from experimental technology to core operational infrastructure across industries.

Entities

Show notes

In this episode, we discuss significant AI-related news, including a personalized cancer vaccine developed with AI tools for a dog, NVIDIA's upcoming AI chip reveal, and OpenAI's major enterprise venture. We also cover Meta's potential large-scale layoffs to fund its ambitious AI spending, highlighting a broader trend of workforce restructuring across the tech industry driven by AI.Chapters00:00 Top AI News Today01:42 AI-Driven Cancer Vaccine for Dog04:18 NVIDIA's Next AI Chip Reveal05:05 OpenAI

Themes

• openai